Tesser, J. Et Al. 2017. CONSISTENT EFFICACY AND SAFETY OF TOFACITINIB IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE OR INTOLERANCE TO NON-MTX CSDMARDS. Annual European Congress of Rheumatology of the European-League-Against-Rheumatism (EULAR) , (Madrid, Spain), 276-277.

Tesser, J., Gul, A., Olech, E., Oelke, K., Lukic, T., Murray, C. W., ... Zhang, C.(2017). CONSISTENT EFFICACY AND SAFETY OF TOFACITINIB IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE OR INTOLERANCE TO NON-MTX CSDMARDS . Annual European Congress of Rheumatology of the European-League-Against-Rheumatism (EULAR) (pp.276-277). Madrid, Spain

Tesser, J. Et Al. "CONSISTENT EFFICACY AND SAFETY OF TOFACITINIB IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE OR INTOLERANCE TO NON-MTX CSDMARDS," Annual European Congress of Rheumatology of the European-League-Against-Rheumatism (EULAR), Madrid, Spain, 2017

Tesser, J. Et Al. "CONSISTENT EFFICACY AND SAFETY OF TOFACITINIB IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE OR INTOLERANCE TO NON-MTX CSDMARDS." Annual European Congress of Rheumatology of the European-League-Against-Rheumatism (EULAR) , Madrid, Spain, pp.276-277, 2017

Tesser, J. Et Al. (2017) . "CONSISTENT EFFICACY AND SAFETY OF TOFACITINIB IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE OR INTOLERANCE TO NON-MTX CSDMARDS." Annual European Congress of Rheumatology of the European-League-Against-Rheumatism (EULAR) , Madrid, Spain, pp.276-277.

@conferencepaper{conferencepaper, author={J. Tesser Et Al. }, title={CONSISTENT EFFICACY AND SAFETY OF TOFACITINIB IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE OR INTOLERANCE TO NON-MTX CSDMARDS}, congress name={Annual European Congress of Rheumatology of the European-League-Against-Rheumatism (EULAR)}, city={Madrid}, country={Spain}, year={2017}, pages={276-277} }